《大行報告》星展降比亞迪(01211.HK)目標價至347元 深化全球策略成為新增長動力
星展發表報告,預期比亞迪(01211.HK)今年銷售增長雖然較去年緩慢,但仍然理想,認為公司的優勢在於廣泛的新能源汽車型號組合以及綜合生產設施,對於推動未來業務增長、維持市場定位有重要作用。公司正擴充至高端汽車市場,特別是客戶更加注重科技、創新及設計,在市場競爭加劇下,新產品的推出有助保障利潤率,由於去年銷量基數高,預期今明兩年新能源汽車銷量分別增長30%及20%,至明年銷量為470萬輛。
該行指,公司開拓海外市場,探化全球策略,將會成為中期增長動力,股價表現將會取決於市場需求及利潤率前景,將比亞迪H股目標價由410元下調至347元,以反映宏觀經濟不明朗因素,評級「買入」。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.